Comparison of Several Oxygenation Targets With Different Oxygen Interfaces - Impact on Oxygen Flow Rates
Launched by LAVAL UNIVERSITY · Oct 16, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of oxygen delivery methods, called interfaces, affect the amount of oxygen flow in patients with respiratory issues like COPD, bronchitis, and respiratory failure. Researchers want to understand how these methods can influence oxygen flow rates and the level of carbon dioxide in the blood, especially when using certain types of oxygen masks that can lead to rebreathing.
To participate in this trial, you need to be an adult aged 18 or older who is currently receiving oxygen therapy and has a specific oxygen saturation level (between 88% and 100% with the usual device). However, if you have certain conditions, like severe anemia or if your oxygen flow is very high (over 6 liters per minute), you may not be eligible. If you take part, you can expect to help researchers learn more about how to improve oxygen therapy for patients like you, which could lead to better care in the future. The trial is not yet recruiting participants, so it will start accepting volunteers soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult (\> or = 18 years old)
- • Ongoing on conventional oxygen therapy with peripheral oxygen saturation (SpO2) between 88 and 100% with the usual oximeter
- • SpO2 \< 92% ambient air with the usual oximeter
- Exclusion Criteria:
- • No SpO2 signal with with the usual oximeter
- • False nails or nail polish
- • Severe anemia documented on last blood count during current hospitalization (haemoglobin (Hb) \< 80g/L)
- • Oxygen flow \> 6 L/min
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quebec, , Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported